Saturday, December 29, 2012

Lupus, TB, and IgG4

Motivation: Recently, I have heard increasing whispers about IgG4 related disease.  In the  list of diseases that are hard to diagnose with widely varying symptoms, long time residents like TB and lupus are being joined by IgG4.  Of course, I have yet to see a single patient with IgG4 related disease personally.  But, when mentioned, I do not know how to fend off the possibility.  So, how do patients with IgG4 typically present?

As way of background, IgG4 related disease has become the topic of much discussion only since 2001, when autoimmune pancreatitis related to IgG4 was first described.  Pathologically, IgG4 related disease is characterized by extensive IgG4+ plasma cell infiltration.

Paper: Zen, Y and Nakanuma, Y. "IgG4-Related Disease: A Cross-Sectional Study of 114 Cases" Am J. Surg. Pathol. (2010); 34: 1812.

Methods: Between 1990 and 2009, pathological samples with diffuse IgG4 plasma cell infiltration were retrieved from case files at Kanazawa University Hospital and affiliated hospitals in Japan.  Clinical features of patients meeting criteria were retrospectively reviewed from medical records.

Results: 
Location: Total of 114 patients with IgG4 related disorder were identified.  Location of disease is as follows:

  • 23 patients (20.1%) with head and neck lesions - primarily salivary gland and lacrimal gland
  • 16 patients (14.0%) with thoracic lesions found in lung, pleura, and breast
  • 27 patients (23.6%) with hepatobiliary lesions in pancreas, bile duct, gallbladder, and liver
  • 13 patients (11.4%) with retroperitoneal disease presenting with retroperitoneal fibrosis and aortitis
  • 35 patients (30.7%) with diffuse systemic manifestations
Demographics: Median age of presentation is 64 with youngest aged 42.  Male and females were almost evenly distributed for the head and neck group.  On the other hand, >70% of the patients were male with thoracic lesions and >80% were male with hepatobiliary, retroperitoneal, and systemic presentations.

Associated Autoimmune Diseases: In the cohort, 22 patients had history of allergy while only 2 had a clinical history of autoimmune disease - one with sarcoidosis and one with rheumatoid arthritis.  Enlarged lymph nodes were found in 47 patients (41%) by physical and radiologic examination.

Serum Concentration of IgG4: IgG subset information was available in 58 patients.  Serum IgG4 was elevated in 50 of 58 patients (86%).  Serum levels of IgG4 were highest in patients with systemic and head & neck disease.

Lesion Features: Of the biopsied lesions, all except one lesion was macroscopic - could be identified by physical exam or by radiology.  When IgG4 related disease affected a solid organ, the pattern of infiltration was either diffuse or as mass-like lesion.

Malignancy: Of 114 patients, 3 patients in the systemic group presented with malignancy during follow-up: small cell carcinoma (1 year after IgG4 diagnosis), adenocarcinoma (2 years later), and B cell lymphoma (4 years later).

Discussion: What I take away from this cross-sectional description is that this oft invoked but little understood disease is very different from traditional auto-immune diseases.  IgG4 related disease can occur in just about any part of the body, but the likely presentation is a macroscopically visible diffusely infiltrative or mass-like lesion.  Besides testing for IgG subsets, there is little to distinguish it (at least in this survey) at first glance from neoplastic disease.  Importantly, the disease does not appear correlated with other auto-immune phenomenon such as lupus or rheumatoid arthritis or paraneoplastic disease.  I think that in the future, we will learn more about historical features, but for now, IgG4 related disease remains hard to diagnose with protean manifestations - just like lupus and TB.

Sunday, December 16, 2012

MRI for C-spine

Motivation: An elderly man trips on ice and falls.  He complains of neck pain in the ED.  He gets a cervical spine CT, which is normal. He still complains of neck pain.  What do you do now?  I think that many doctors would follow different strategies.  Some would take off the cervical collar and provide ibuprofen.  Others would continue imaging with MRI.  What is the right approach?

As way of background, for cervical spine injury, potentially dangerous ligamentous injuries remain on the differential even after a negative CT.  What is less clear is the incidence of these injuries and the clinical significance of these findings.

Paper: Schoenfeld, A.J., Bono, C.M., McGuire, K.J. et. al. "Computed Tomography Alone versus Computed Tomography and Magnetic Resonance Imaging in the Identification of Occult Injuries to the Cervical Spine: A Meta-Analysis" J. Trauma. (2010); 68(1): 109.

Methods: Meta-analysis of prospective and retrospective studies of MRI after negative CT.  True positive MRI was defined as change in clinical management per clinician judgement.

Results:
Studies: Eleven studies were identified evaluating 1,550 blunt trauma patients evaluated initially by CT and then by MRI.  None of the trials were randomized controlled trials.

Abnormalities: Of the entire cohort, 194 MRI abnormalities were detected in 182 patients (12% of cohort) with negative CT scans.  Of these abnormalities, majority (86, 47% of abnormalities) were ligamentous injuries.  Other significant injuries detected were: degenerative changes (47, 24% of abnormalities),  cord contusion (16, 8.2% of changes), fracture (3, 1.5% of changes), and cord contusions (16, 8.2% of changes).

Clinical Outcomes: As a result of MRI, 84 patients (5% of cohort) required prolonged use of collar, and 12 patients (1% of cohort) required cervical stabilization.  In 86 patients (5.5% of patients), MRI findings were judged clinically insignificant.  For MRI, the pooled sensitivity was 100%, and the pooled specificity was 94%.

Discussion: This paper surprised me with the number of clinically significant injuries missed on CT scanning. About 1% of patients required operative intervention after an apparently normal CT scan.  Similarly, about 1% of patients had cervical cord contusions despite a negative CT scan.  What is not apparent from this paper though are the factors predictive of positive MRI findings with a negative CT scan.  In the absence of clear prospective data, I would think that persistent neck pain or any neurological findings calls for an MRI scan despite a negative CT scan.  So, in summary, if an elderly man continues to complain of neck pain even with a negative CT, I would recommend a cervical MRI.

Thursday, December 6, 2012

Back Brace

Motivation: I have never worn body armor, but a thoracolumbar brace looks close to it.  I often see the full body brace clipped onto elderly women after a compression fracture of the spine from a fall, and I wonder if it actually does anything besides making for a closeted experience.  Although there are many practices in surgery without evidence, turns out that this idea has actually been tested in a single randomized trial.

Paper: Stadhouder, A., Buskens, E., Vergroeen, DA, et. al. "Nonoperative treatment of thoracic and lumba spine fractures: a prospective randomized study of different treatment options." J Orthop. Trauma (2009); 23: 588.

Methods: Randomized trial carried out in Amsterdam.  Patients younger than 80 with traumatic thoracic or lumbar compresssion fractures ( less than 50% disc height loss or 30% spinal canal stenosis) without neurological impairment were randomized to (1) physical therapy for 6 weeks, (2) removable brace for 6 weeks, or (3) plaster of paris cast for 6 or 12 weeks.  No single primary outcome pre-specified.  Parameters followed included radiographic improvement, pain measure, and disability index meaurd at 6 weeks, 12 weeks, 6 months, and 12 months.

Results:
Cohort: Total of 108 patient were randomized with 54.1% women with mean age of 45.  Baseline measurements such as gender distribution, age, and admission time were similar among groups.  Majority of patients had high-energy trauma.

Tolerability: For compression fractures, physical therapy was better tolerated than plaster of paris but not significantly different than brace therapy.  Brace therapy was also better tolerated than plaster of paris therapy.

Residual Pain: At long term follow-up (1 year later), visual analogue scale residual pain was significantly less for brace compared to plaster of paris therapy for 12 weeks (mean difference 19.0, CI: 1.87-36.2).  There was no difference between physical therapy and brace therapy or between brace therapy and cast for 6 weeks.

Disability Index: At long term follow-up, measure by Owestry Disability Index, brace therapy for 6 weeks was superior to physical therapy (mean difference 14.9, CI: 2.7-27.1) and cast for 12 weeks (mean difference 10.1, CI: 0.25-25.0) or 6 weeks.

Discussion: I think that this paper represents one of the many cases in medicine where an exploratory trial of limited power has been generalized to a wide population.  The patients in the trial were primarily in their 40s presenting after a high-impact accident.  These patients are clearly different than the elderly patients with osteoporotic compression fractures encountered in clinical practice.  Moreover, the trial itself suffers from several notable flaws with perhaps the lack of a pre-specified primary outcome being the most significant one.  Even for the significant outcomes, the confidence intervals are very wide.  While a brace makes pathophyiological sense for treating fractures, the treatment choice for compression fractures remains an area of uncertainty.

Friday, November 23, 2012

CNS Tuberculosis

Motivation: As one of my attendings put it after morning rounds filled with arcane diagnoses, "By the time you end up at MGH, you the definition of atypical."  One of the atypical diagnoses we often consider is central nervous system tuberculosis - entering into the differential for both persistent meningitis and brain masses.  Every time you mention CNS TB, some smirk while others edge towards a face mask.  I am torn between the two largely because I do not know what the typical presentation is or even how to diagnose it prior to a culture that takes weeks to mature.  So, how do you diagnose CNS TB?

As way of background, central nervous system tuberculosis is thought to occur from hematogenous spread of TB from a primary pulmonary focus.  There is TB deposition and formation of subpial and subependymal foci - called Rich foci.  If these foci rupture, TB meningitis results.  Otherwise, growth of these foci results in tuberculomas.

Paper: Systematic review of diagnoses of CNS TB by British Infectious Society. "British Infectious Society guidelines for the diagnosis and treatement of tuberculosis of the central nervous system in adults and children" Journal of Infection (2009); 59: 167-187.

Methods: Systematic clinical evidence review of papers published in Medline and Pubmed between 1966 and 2008 dealing with CNS TB.  The working group consisted of an interdisciplinary group of specialists.

Results:
Basic Clinical and Laboratory Features of CNS TB:
TB Meningitis: The top three clinical features were fever (60-95%), headache (50-80%), and anorexia/weight loss (60-80%).  Top three clinical signs were neck stiffness (40-80%), focal cranial nerve palsy (30-50%), and coma (30-60%).  On CSF examination, majority have clear appearance (80-90%) with 50% having opening pressure > 25 cm H2O.  CSF glucose:blood glucose ratio was < 0.5 in 95% of patients with TB meningitis.  The leucocyte count varies between 5-1000 cells with variable neutrophilic and lymphocytic predominance.  Protein was also variable ranging from 45 to 300 mg/dL.
CNS Tuberculoma: Few large case series but most common presenting feature is seizure with complaints of headache, fever, and weight loss.  CSF pleocytosis of 10-100 cells is present in only 50%.

Microbiology:
TB Meningitis: Sensitivity of AFB smear up to 80% provided that multiple large volume (>6 mL) taps are submitted for analysis.  Culture media usually takes > 2 weeks to be positive and not helpful with decision making.
Tuberculoma: CSF AFB smear usually not positive and require stereotactic biopsy, which is diagnostic in about 94% of patients.

Nucleic Acid Amplification:
TB Meningitis: Currently available nuceic acid amplification tests about 56% sensitive (95% CI 46-66%) and 98% specific (95% CI 97-99%).  After start of anti-TB treatment, PCR test may retain sensitivity even when AFB smear turns negative.  PCR methods of CSF have not been well studies with tuberculomas.

PPD: Rates of positive PPD with CNS TB vary widely with reported ranges around 10-50%.
CSF adenosine deaminase activity: Unclear sensitivity (estimated around 57%) with CNS TB but lack of specificity with false positives from lymphoma, malaria, crytococcoal meningitis, and other etiologies.

Interferon-gamma release assay: Estimated sensitivity of about 50% since CSF lymphocytes may die more rapidly than peripheral lymphocytes.

Discussion: Analysis of the literature supports why TB occupies such a murky place in the differential for brain masses or meningitis.  There are no very sensitive ways to prove TB meningitis.  In some sense, the history of subacute onset of symptoms with a suggestive CSF profile is the best clue for TB meningitis.  The rest of diagnostic tests are not sensitive enough to rule out TB meningitis over clinical suspicion alone.  One point that I was especially surprised to learn is that although TB is acquired via pulmonary source and spread hematogenously, the PPD is positive in only 50%.  Other assays like CSF adenosine deaminase or even interferon-gamma release assay are relatively insensitive.  So, one has to be careful to over-rule clinical suspicion!

Monday, October 29, 2012

Tackling Nerve Pain


Motivation: Pain is the bane of internists - particularly neuropathic pain. The gnawing, burning pain keeps people (patients and internists) up all night debating whether to use IV opioids.  And, gabapentin hardly seems up to the job.  There were several instances last year when even mega-doses of gabapentin failed to lessen the pain.  I often wondered at that point, what next?  To start a new agent, should I stop gabapentin? (And, is this pain real?)

During a clinic this year, one of the attendings pointed out a helpful trial that attempted to deal with failed control of neuropathic pain.  The trial tested combination of tricylcic agent nortriptyline with gabapentin.  As way of background, gabapentin is an alkylated analogue of GABA that is actually thought to work through modulating calcium channel subunits.  Nortriptyline is derived from amitriptyline with multiple effects including blockade of norepinephrine and serotonin re-uptake, blockade of sodium channels, anti-cholinergic actions, and antagonism of NMDA receptors.

Paper: Gilron, I., Bailey, J.M., Tu, D. et. al. "Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial" Lancet (2009); 374: 1252.

Methods: Double-blind crossover trial in patients with diabetic polyneuropathy and postherpetic neuralgia with persistent neuropathic pain. Randomized trial of three treatments - gabapentin, nortriptyline, and combined gabapentin and nortriptyline.  In crossover design, each of three groups spent 6 weeks in each of the three treatment groups (received placebo pill for second agent when getting just gabapentin or nortriptyline).  After 6 weeks, each of the groups were switched to one of the other three treatment assignements.  During the trial period, drug doses were titrated to maximum tolerated dose.  Primary outcome was mean daily pain (0-10 rating scale).

Results:
Subjects: The trial enrolled total of 56 participants.  Of these patients, 40 had diabetic polyneuropathy and 16 had post-herpetic neuralgia.  All of the patients were white with men comprising 65% of diabetic groups and 56% of post-herpetic neuralgia group.  In the diabetic group, 20% were taking opioids with about 33% having been exposed to prior tricyclic and 20% having been exposed to gabapentin/pregabalin.  Similarly, in the post-herpetic neuralgia group, 25% were taking opioids with about 31% having been exposed to prior tricyclic and 44% having been exposed to gabapentin/pregabalin.

Gabapentin vs. Nortriptyline: As monotherapy, both gabapentin and nortriptyline achieved lower daily pain intensity compared to baseline (5.4 in baseline vs. 3.2 for gabapentin; 5.4 vs. 2.9 for nortriptyline). The pain rating is significantly lower from baseline but is not significantly different between drugs.  Similarly, neither drug was superior to each other in terms of worst pain in 24 hours, least pain in 24 hours, or percentage pain relief on treatment.

Combination Therapy: Combined nortriptyline and gabapentin was significantly superior to gabapentin and nortriptyline monotherapy in terms of daily pain intensity (2.3 in combination vs 3.2 for gabapentin alone, p=0.001; 2.3 vs 2.9 for nortriptyline, p=0.02).  Combination therapy also provided better percentage pain relief on treatment (63.4% vs. 48.1% for gabapentin, p=0.007; vs. 45.7% for nortriptyline, p=0.002).  In secondary analysis, Beck depression score was significantly better for combination therapy compared to nortriptyline (5.4 vs. 6.8 for nortriptyline, p=0.01).  Self-reprorted vitality was also higher with gabapentin and combination therapy compared to nortriptyline alone. Depression scores were not different between combination therapy and gabapentin.

Dosage: As monotherapy, average maximum doses of gabapentin was 2433 mg/day while that of nortriptyline was 61.6 mg/day.  In combination, average gabapentin dose was 2180 mg/day and nortriptyline dose was 50.1 mg/day.

Adverse Effects: No serious side effects were noted.  Dry mouth was more frequent with nortriptyline while inability to concentrate was more frequent with gabapentin.

Discussion: For patients with poorly controlled neuropathic pain, combination therapy with nortriptyline and gabapentin was superior to monotherapy.  While both drugs appeared to be equivalent in terms of controlling pain, I was surprised at the worse depression scores and decreased vitality with nortriptyline monotherapy compared to gabapentin.  Given the alternate use as anti-depressant, I would have expected nortriptyline to be at least as good as gabapentin in terms of mood.  This analysis is, of course, secondary and limited by the small number of subjects (56 total patients), but given the limited data, I would start with gabapentin monotherapy and then add nortriptyline as an adjunctive agent.  Another cautionary note is that the tolerated doses of gabapentin in the trial was more than 2000 mg/day.  With the usual starting dose of 300 mg thrice daily, the drug needs to be significantly uptitrated prior to pronouncing therapeutic failure.

Sunday, October 21, 2012

Preserve your wisdom

Motivation: I dislike going to the dentist.  I do not mind the whining drill, but after finishing poking through my teeth, every dentist tells me to take out all my wisdom teeth.  And, I have resisted for more than a decade.  In few other fields of medicine are prophylactic painful procedures so prevalent for a less than life-threatening outcome - a cavity in a wisdom tooth.  To further solidify my argument for my next visit, I wondered about the data backing this recommendation.

As way of background on dentistry, current American guidelines recommend extracting wisdom teeth that fail to erupt completely ("impacted wisdom teeth" in dentistry parlance) preferably during adolescence.  Since no randomized trials exist in adults, reviewed below is a paper which examines the strength of existing evidence.

Paper:  Shallu, B. and Rajesh, S. "Is it Wisdom to Remove a Wisdom Tooth? - Extraction versus nonextraction Management of Impacted Tooth" Ind. J. of Den. Sci. (2010); 2: 4-6

Results:
Incidence of Pathology in Wisdom Teeth: When followed for four years, about 10% of non-erupted wisdom teeth result in adults develop surrounding gingival inflammation or pericoronitis.  There is low incidence (less than 1%) of root resorption in surrounding molar teeth as a result of non-erupted wisdom teeth.  Incidence of inflammation spreading from wisdom teeth to surrounding teeth (ie. causing dental caries) is estimated at 1 to 4.5%.

Early Removal of Wisdom Teeth vs. Later Removal: In post-intervention series, persons aged 35 to 83 years of age were less likely to experience dry socket, secondary infection, and parasthesias compared to those aged 12-24.  The highest risk of complications occurred in people aged 25 to 34 years.

Erupting Wisdom Teeth Causing Crowding of Anterior Teeth: Primarily theoretical prediction without substantial longitudinal clinical data.  (From a Cochrane review), a single trial comparing outcomes at 5 years did not find substantial differences between tooth extraction and observation.

Discussion: I think that I will take the one out of ten chance that keeping wisdom teeth may result in pathology in the next four years.  There are no data to support benefits of early asymptomatic extraction.  In fact, in England, the governmental health organization, NICE, recommended against prophylactic removal of asymptomatic wisdom teeth.  A similar Cochrane review on this topic also found insufficient evidence.  I was personally surprised at the lack of data given the estimated mutli-billion dollar industry among oral surgeons dedicated to wisdom tooth removal.  I think that like other similar problems in medicine such as with gallstones, preventive intervention may not be justified on a population basis. 

Friday, October 12, 2012

Is High Fructose Corn Syrup Unhealthy?


Motivation: Somehow we all know it - high fructose corn syrup makes you gain weight. I cannot remember when I first heard it or when I last read something about it, but this notion is spreading from the health community outwards.  I even had a patient ask me about avoiding foods with high fructose corn syrup.  Not knowing much beyond rumors, I felt that it was time to investigate the merits of different kinds of sugars.  What is the data linking high fructose corn syrup to the epidemic of obesity and diabetes?

As way of background, regular sugar consists of sucrose, which is a disaccharide of fructose and glucose.  High fructose corn syrup (HFCS), in contrast, consists of monosaccharides with varying concentrations of fructose and glucose (from 42% to 90% fructose).

Paper: Forshee, R.A., Storey, M.L., Allison, D.B. et. al. "A Critical Examination of the Evidence Relating High Fructose Corn Syrup and Weight Gain" Crit. Rev. in Food Sci. and Nut. (2007); 47:561-582.

Method: Systematic review conducted by expert panel convened by Center for Food, Nutrition, and Agriculture Policy to examine the evidence linking HFCS and changes in BMI/body weight.

Results:
The strength of evidence from different classes of evidence are summarized below. Given the breadth of evidence, only significant studies are presented:

Ecological Studies: These are large scale studies linking trends between food consumption and health measures.  Between 1909 to 1997, incidence of type 2 diabetes was positively and significantly correlated with corn syrup intake along with intake of fat, total carbohydrate, protein, and total energy.  Using food-consumption data to estimate sweetener consumption from 1962 to 2000, the authors found a 74 kcal/person increase in per capita sweeter availability in this time period.  No causality with disease is implicated in this study.

Cross-Sectional Studies: Four studies were identified examining relationship between soft or sweetened drink consumption (proxy for HFCS) and obesity.  Three out of four studies found that sweetened regular soft drinks were not significantly associated with BMI. One study among European American children showed positive association between overweight and sweetened beverages along with association with consumption of increased total food and beverages.

Longitudinal Studies: Four studies examined growing children and sweetened drink consumption.  Three out of these four studies did not find any association in excess of total calories consumed.  One study showed that over 19 months, BMI increased by 0.24 units for every additional serving of sweetened drink.

Among adults, when 38,480 women health professionals were followed, total caloric sweetener (fructose or glucose) consumption did not correlate to risk of type 2 diabetes.  Another study also examined sweetened beverage consumption among women 24-44 for 15 years and did not find excess weight gain among high consumers of sweetened beverages.  The study did find that women who moved from low consumption to high consumption were at higher risk of weight gain.

Controlled Trial: Only one RCT has been performed to test this question among children 7-11 years of age.  The intervention group received education emphasizing healthy diet and discouraged sweetened and carbonated beverages.  Mean percentage of overweight and obese children decreased in the intervention arm.

Discussion: In summary, the evidence linking high fructose corn syrup and obesity is circumstantial at best.  The overall upward trend in obesity and diabetes can also be explained by increased caloric intake - which has paralleled the weight gain the past few decades.  Of course, the evidence also does not conclusively refute the hypothesis that HFCS is in part responsible for accelerating obesity.  Given the complex interactions between food habits and general health habits, it is hard to see how anything besides a randomized trial can provide more definitive evidence.  For now, though, to avoid obesity and diabetes, limiting caloric intake is likely a better idea than avoiding high fructose corn syrup.